Inactive Instrument

Insiders Q BioMed Inc. Other OTC

Equities

Q BioMed : Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World	20-08-11	PR
Q BioMed Inc. Announces Appointment of Geoff Fatzinger as Global Head of Regulatory Affairs	20-03-31	CI
Q BioMed Inc. Announces Appointment of Kristin Keller as Chief Commercial Officer	20-03-30	CI
Q BioMed Inc. Appoints Pamela Ventola ato its Advisory Committee for its QBM-001 Clinical Program	19-01-16	CI
Q BioMed Inc. Announces Dr. Rajendra Apte Joins Advisory Board	18-09-17	CI
Q Biomed Inc. Appoints Riccardo Panicucci as Director	18-02-20	CI
Q BioMed Inc. Appoints Tager-Flusberg to Advisory Committee	17-11-28	CI
Q BioMed Inc. Names Christopher Manuele to Strontium 89 Chloride Commercialization Team	17-06-26	CI
Q Biomed Inc. Appoints Amy Ripka and Rick Panicucci to Board of Scientific Advisors	17-04-13	CI
Q Biomed Inc. Appoints David Laskow-Pooley as VP Scientific & Product Development	15-12-16	CI
Q BioMed Inc. Announces Additions to its Advisory Board	15-11-12	CI
Q BioMed Inc. Appoints Denis Corin to the Positions of Chief Executive Officer and Chairman of the Board of Directors	15-10-09	CI
Enriques Navas Resigns as Director of Q Biomed Inc	15-08-03	CI
ISMO Tech Solutions, Inc. has Changed its Name to Q BioMed Inc	15-07-30	CI
ISMO Tech Solutions, Inc. Elects William Rosenstadt to Board	15-06-16	CI
ISMO Tech Solutions, Inc. Appoints Denis Corin to its Board of Directors	15-04-30	CI

No results for this search